RAM
IMMU

Riggs Asset Management’s Immunomedics Inc IMMU Stock Holding History

Riggs Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-3,000
Closed -$11K – 322
2014
Q3 		$11K Buy
+3,000
New +$10.1K 0.01% 206

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Riggs Asset Management's IMMU Position: Q4 2014 in Review

Riggs Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2014, closing a stake of 3,000 shares — an estimated $11K sold.

Riggs Asset Management first reported a position in IMMU in Q3 2014 and held it in 1 quarter. The position peaked at $11K in Q3 2014. 85 funds tracked by Wall St. Rank hold IMMU as of Q4 2014.

  • Riggs Asset Management reported no remaining Immunomedics Inc position as of Q4 2014 after selling out during the quarter.
  • Riggs Asset Management sold 3,000 Immunomedics Inc shares in Q4 2014, an estimated $11K.
  • Riggs Asset Management first reported a position in Immunomedics Inc in Q3 2014 and held it in 1 quarter.
  • Riggs Asset Management's Immunomedics Inc position peaked at $11K in Q3 2014.
  • 85 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2014.

Based on Riggs Asset Management's 13F filing for Q4 2014, filed 4 Feb 2015.